ANGIODYNAMICS INC
For the period ended Feb 28, 2026. Filed Apr 2, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Feb 28, 2026 · Filed Apr 2, 2026
ANGO$12.12+3.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
Item 6
| EXHIBIT INDEX · Incorporated by Reference | ||||
|---|---|---|---|---|
| No. | Description | Form | Exhibit | Filing Date |
| 10.1 | Transition and Retirement Agreement, dated as of February 3, 2026, by and between AngioDynamics, Inc. and James C. Clemmer | 8-K | 10.1 | February 3, 2026 |
| 10.2 | Form of AngioDynamics Retention Incentive Letter Agreement | 8-K | 10.2 | February 3, 2026 |
| 31.1 | Certification pursuant to Rule 13a-14(a) or 15d-14 under the Securities Exchange Act of 1934 | |||
| 31.2 | Certification pursuant to Rule 13a-14(a) or 15d-14 under the Securities Exchange Act of 1934 | |||
| 32.1 | Certification of Chief Executive Officer pursuant to Title 18, United States Code, Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |||
| 32.2 | Certification of Chief Financial Officer pursuant to Title 18, United States Code, Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |||
| 101.INS | The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document | |||
| 101.SCH | XBRL Schema Document | |||
| 101.CAL | XBRL Calculation Linkbase Documents | |||
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | |||
| 101.LAB | XBRL Labels Linkbase Documents | |||
| 101.PRE | XBRL Presentation Linkbase Documents | |||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101 | |||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| ANGIODYNAMICS, INC. | ||
| (Registrant) | ||
| Date: | April 2, 2026 | / S / JAMES C. CLEMMER |
|---|---|---|
| James C. Clemmer, President,Chief Executive Officer(Principal Executive Officer) | ||
| Date: | April 2, 2026 | / S / STEPHEN A. TROWBRIDGE |
| Stephen A. Trowbridge, Executive Vice President,Chief Financial Officer(Principal Financial and Accounting Officer) | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.